Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Recruiting now NCT05403177
Run by University Health Network, Toronto · for 18 and older · All sexes
What this study is about
The Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment and prevention that considers individual variability in DNA, environment and lifestyle) to accelerate the discovery of innovations and improve the health outcomes for cancer patients
Who can join (things the study team will check)
✅ You may be able to join if…
- Patients with histological and/or cytological confirmation of blood or solid tumor malignancies. For tumour types where pre-surgical biopsy is not routinely performed to confirm a pathologic diagnosis of cancer, patients may consent to this protocol, but eligibility must be confirmed after pathology is finalized demonstrating presence of malignancy
- All patients must be able to satisfy the required minimum data elements for the 15k gold standard cohort through:
- Already existing data that satisfies the minimal requirements of a gold standard case (refer to Table 1)
- Have sufficient biospecimens (tumor and/or blood samples) available for more comprehensive molecular and immunophenotypic characterization
- Patients who do not satisfy the required minimum data elements but would like to participate, maybe requested to donate blood and undergo a fresh biopsy if the archived Formalin-fixed paraffin-embedded (FFPE) samples are not available, or in cases where a fresh tumor biopsy is deemed necessary for molecular profiling.
- Participating patients must agree to share their anonymized clinical and genomic data
Where this trial is running
- Kingston Health Sciences Centre, Kingston, Ontario, Canada
- Ottawa Health Research Institute, Ottawa, Ontario, Canada
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Who to contact
PM2C Central Office · 416-946-4501 · MOHCCN@uhn.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05403177.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.